Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: a feasibility study

15Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: To assess the feasibility of microwave ablation (MWA) in treating ectopic secondary hyperparathyroidism (SHPT) in patients with chronic renal failure. Methods: In this retrospective study, MWA was used to manage 22 SHPT nodules in 20 patients. The laboratory test results, including intact parathyroid hormone (iPTH), serum calcium, phosphorus and alkaline phosphatase (ALP) levels; clinical symptoms; complications before, at one day after MWA, and at the end of follow-up were recorded and compared. Both echogenicity and size of SHPT nodules on ultrasound were documented before and after MWA. Results: iPTH levels decreased from 1106 ± 396 pg/mL to 264 ± 251 pg/mL (p

Cite

CITATION STYLE

APA

Li, X., Wei, Y., Shao, H., Peng, L., An, C., & Yu, M. A. (2019). Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: a feasibility study. International Journal of Hyperthermia, 36(1), 647–653. https://doi.org/10.1080/02656736.2019.1627429

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free